Correlation Between Apogee Therapeutics, and National CineMedia
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and National CineMedia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and National CineMedia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics, Common and National CineMedia, you can compare the effects of market volatilities on Apogee Therapeutics, and National CineMedia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of National CineMedia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and National CineMedia.
Diversification Opportunities for Apogee Therapeutics, and National CineMedia
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Apogee and National is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and National CineMedia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on National CineMedia and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with National CineMedia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of National CineMedia has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and National CineMedia go up and down completely randomly.
Pair Corralation between Apogee Therapeutics, and National CineMedia
Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to under-perform the National CineMedia. In addition to that, Apogee Therapeutics, is 1.73 times more volatile than National CineMedia. It trades about -0.06 of its total potential returns per unit of risk. National CineMedia is currently generating about 0.0 per unit of volatility. If you would invest 685.00 in National CineMedia on September 21, 2024 and sell it today you would lose (11.00) from holding National CineMedia or give up 1.61% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Apogee Therapeutics, Common vs. National CineMedia
Performance |
Timeline |
Apogee Therapeutics, |
National CineMedia |
Apogee Therapeutics, and National CineMedia Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Apogee Therapeutics, and National CineMedia
The main advantage of trading using opposite Apogee Therapeutics, and National CineMedia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, National CineMedia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in National CineMedia will offset losses from the drop in National CineMedia's long position.Apogee Therapeutics, vs. National CineMedia | Apogee Therapeutics, vs. BorgWarner | Apogee Therapeutics, vs. Marine Products | Apogee Therapeutics, vs. Radcom |
National CineMedia vs. Mirriad Advertising plc | National CineMedia vs. INEO Tech Corp | National CineMedia vs. Kidoz Inc | National CineMedia vs. Snipp Interactive |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Transaction History View history of all your transactions and understand their impact on performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |